Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004909 · ClinicalTrials.gov registry record
Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 40
- Enrollment target
NCT00004909 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 40 participants.
The verdict
NCT00004909 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of the treatment on these patients. PURPOSE: This clinical trial studies the effects of chemotherapy given by mouth versus chemotherapy given by infusion on quality of life in patients with recurrent ovarian epithelial cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1999-11 |
| Est. Completion | 2002-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004909
The ClinicalTrials.gov registry entry for NCT00004909 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00004909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004909 about?
NCT00004909 is a clinical study titled "Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer". RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of the treatment on these patients. PURPOSE: This clinical trial studies the effects of chemotherapy given by mouth versus chemotherapy given by infusion on quali...
What is the current status of trial NCT00004909?
This trial is currently completed. The enrollment target is 40 participants. The study started on 1999-11. Estimated completion is 2002-11.
Who is sponsoring clinical trial NCT00004909?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.